Tagged: Health and Education
17 Feb – Pharmaceutical giant GlaxoSmithKline should be congratulated for breaking industry ranks and taking a major step toward helping poor people in developing countries to get better access to medicines, says international agency Oxfam. However GSK’s initiative this week is just the beginning.
Rich country donors and the World Bank are wasting money and risking lives by continuing to push unproven and discredited private healthcare programs in poor countries. Oxfam’s warning comes in a new report ‘Blind Optimism: Challenging the myths about private health care in poor countries’.
Sierra Leone has one of the highest maternal mortality rates in the world. Investment in maternal health and improvements in the efficiency of spending could help save lives.
In Afghanistan, a woman dies every 27 minutes thanks to pregnancy-related complications.